Teladoc Health TDOC - Initial position started at $9.91 with the potential for the price gap in the $7's to be closed in the near future (likely another entry there unless fundamentals change)
Pros:
User base of over 90 million and growing
Revenue grew from $555 million in 2019 to $2.6 billion through Q3 of 2024
Positive free cash flow since 2021
Low debt (debt to equity ratio around 1x)
AI integration and partnership with Amazon and Brightline
Historical simply moving average is approaching price, which often leads to a jump or change in downward momentum in the longer-term
Cons:
Currently unprofitable and not forecast to become profitable over the next 3 years
Lots of insider selling and exercising of options
No dividend
Daily price gap in the $7 dollar range which may close prior to move up
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.